Stockreport

Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2025 Financial Results

Vir Biotechnology, Inc.  (VIR) 
PDF - ECLIPSE 1 enrollment completed approximately two months ahead of schedule; ECLIPSE 2 and ECLIPSE 3 progressing with strong enrollment momentum, with topline data for a [Read more]